ed that its technical advisory group had ruled that benefits of the shot, known as Covaxin, significantly outweighed the risks and that it met WHO standards for protection against COVID-19.
Stuck in a village in southern India for nine months and unable to return to his job in Saudi Arabia, Sugathan P.R. said he was very happy to hear the news. The listing procedure is a prerequisite for COVAX vaccine supply and allows countries to speed up their own regulatory approval to import and administer COVID-19 shots, the WHO said in its statement.
"It is important for Bharat Biotech to improve its production capacity to meet the improved demand for other countries following this approval," said Prashant Khadayate, a pharma analyst at GlobalData.
When you say home grown 🙄🙄 COVID19 vaccine
Lol home grown aye? Like a weed plant on a flowerpot ? Bad headline!!
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: latimes - 🏆 11. / 82 Read more »